CACNA1H and peripheral neuropathy: In this report we cannot confirm that our peptide is acting specifically on the CaV3.2, however we report that TAT-CBD3 and TAT-CBD3A6K are effective in blocking T-type channels in sensory neurons and also effectively block AIDS therapy-induced painful peripheral neuropathy in vivo.